No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: A [123I]-β-CIT SPECT-study

European Neuropsychopharmacology

Volumn 11, Issue 1, 2001, Pages 69-74

  Stamenkovic, Mara ^a   Schindler, Shird Dieter ^a   Asenbaum, Susanne ^b   Neumeister, Alexander ^a   Willeit, Mathäus ^a   Willinger, Ulrike ^c   De Zwaan, Martina ^a   Riederer, Franz ^a   Aschauer, Harald N ^a   Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b University Clinic of Neurology   (Austria)

^c University Hospital for Ear Nose Throat   (Austria)

Author keywords

123I CIT (2 carbomethoxy 3 (4 iodophenyl) tropane; Dopamine transporter; Single photon emission computed tomography (SPECT); Tourette's disorder (TD)

Indexed keywords

(2 BETA CARBOMETHOXY 3 BETA (4 IODOPHENYL) TROPANE I 123; DOPAMINE TRANSPORTER; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BASAL GANGLIA; COCAINE; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOURETTE SYNDROME;

EID: 0035104825     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(00)00134-6     Document Type: Article

References (23)

1. Imaging of dopamine transporter with iodine-123-β-CIT and Spect in Parkinson's disease
2. Un grave sindrome ticcosa guarita con haloperidol
3. 2 receptor locus as a modifying gene in neuropsychiatric disorders
4. Untying the gordian knot: the genetics of Tourette syndrome
5. PET study of [C-11] β-CIT binding to monoamine transporters in the monkey and the human brain
6. The dopamine transporter protein gene (SLC6A3): primary linkage mapping and linkage studies in Tourette syndrome
7. 99 mTc-HMPAO SPECT study
8. Dopamine receptor availability in Tourette's syndrome
9. 123I]-β-CIT SPECT correlates of vocal tic severity
10. Tourette's syndrome a model neuropsychiatric disorder
11. SPECT imaging of dopamine and serotonine transporters with [123-I]β-CIT: pharmacological characterization of brain uptake in non-human primates
12. Gilles de la Tourette syndrome: emerging areas of clinical research
13. The Yale global tic severity scale: initial testing of a clinician-rated scale of tic severity
14. 123I]-β-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
15. Exacerbation of tics following antidepressant therapy in a case of Gilles de la Tourette syndrome
16. The Gilles de la Tourette syndrome: current status
17. Un cas de maladie des Tics de Gilles de la Tourette gueri par le R-1625
18. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome
19. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome
20. Dopamine transporter re-uptake sites measured by [11C]WIN 35,428 PET imaging are elevated in Tourette syndrome (abstract)